Alzheimer's Clinical Study Information


The Resonator™ device uses electro-magnetic stimulation in order to relieve symptoms of a disorder or disease.

 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

 
 
 
 
   
   

Post Treatment

Month 1 Post- and Month 2 Post-Treatment Evaluations
At 1 and 2 months after the last study treatment administration, the following procedures and assessments will be conducted by the Principal Investigator, psychometrician and/or cognitive rater:

Medical Measurements

  • Height
  • Weight
  • Blood pressure

Month 1 - Cognitive Assessments and Subject/Study Partner Interviews

  • Neuropsychiatric Inventory Questionnaire (NPI)
  • Clinical Dementia Rating Scale (CDR)
  • Modified Activities of Daily Living (ADL) Inventory

Month 2 – Cognitive Assessments and Subject/Study Partner Interviews

  • Alzheimer’s Disease Assessment Scale-Cog (ADAS-cog)
  • Neuropsychiatric Inventory Questionnaire (NPI)
  • Clinical Dementia Rating Scale (CDR)
  • Modified Activities of Daily Living (ADL) Inventory
  • Mini-Mental state examination (MMSE)

A chart of study visit procedures can be found in Appendix C.


 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.